{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:56:37Z","timestamp":1762624597336,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejpb.2021.03.013","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T19:20:29Z","timestamp":1616872829000},"page":"38-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The effect of hypergravity in intestinal permeability of nanoformulations and molecules"],"prefix":"10.1016","volume":"163","author":[{"given":"Cl\u00e1udia","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack J.W.A.","family":"van Loon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2021.03.013_b0005","doi-asserted-by":"crossref","unstructured":"Sarmento, B.; Ferreira, D.; Vasconcelos, T., Polymer-Based Delivery Systems for Oral Delivery of Peptides and Proteins. In Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines, Jorgensen, L.; Nielsen, H. M., Eds. John Wiley & Sons, Ltd: 2009; pp 207-227.","DOI":"10.1002\/9780470688397.ch11"},{"issue":"7","key":"10.1016\/j.ejpb.2021.03.013_b0010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/1389201015666140915150312","article-title":"Antihyperglycemic potential of incretins orally delivered via nano and microsystems and subsequent glucoregulatory effects","volume":"15","author":"Araujo","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2021.03.013_b0015","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2174\/1389201015666140915152330","article-title":"Targeting membrane transporters and receptors as a mean to optimize orally delivered biotecnhological based drugs through nanoparticle delivery systems","volume":"15","author":"Pereira","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2021.03.013_b0020","first-page":"9","article-title":"Nanoparticle targeting to inflamed tissues of gastrointestinal tract Current","volume":"10","author":"Moulari","year":"2013","journal-title":"Drug Delivery"},{"issue":"3","key":"10.1016\/j.ejpb.2021.03.013_b0025","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0016-5085(89)90897-4","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ejpb.2021.03.013_b0030","first-page":"1130","article-title":"Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation","volume":"5","author":"Kim","year":"2013","journal-title":"Integrat. Biol. Quantitative Biosci. Nano to macro"},{"issue":"2","key":"10.1016\/j.ejpb.2021.03.013_b0035","doi-asserted-by":"crossref","first-page":"C566","DOI":"10.1152\/ajpcell.00418.2006","article-title":"Estradiol and dihydrotestosterone regulate endothelial cell barrier function after hypergravity-induced alterations in MAPK activity","volume":"293","author":"Sumanasekera","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.ejpb.2021.03.013_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144269","article-title":"Transient Intervals of Hyper-Gravity Enhance Endothelial Barrier Integrity: Impact of Mechanical and Gravitational Forces Measured Electrically","volume":"10","author":"Szulcek","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2021.03.013_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fspas.2016.00026","article-title":"Hypergravity as a tool for cell stimulation: implications in biomedicine","volume":"3","author":"Genchi","year":"2016","journal-title":"Frontiers in Astronomy and Space Sciences"},{"issue":"12","key":"10.1016\/j.ejpb.2021.03.013_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243098","article-title":"Hypergravity as a gravitational therapy mitigates the effects of knee osteoarthritis on the musculoskeletal system in a murine model","volume":"15","author":"Dechaumet","year":"2020","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.ejpb.2021.03.013_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197594","article-title":"Hypergravity enhances the therapeutic effect of dexamethasone in allergic asthma and rhinitis animal model","volume":"13","author":"Jang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejpb.2021.03.013_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2020.08.005","article-title":"Engineered albumin-functionalized nanoparticles for improved FcRn binding enhances oral delivery of insulin","volume":"327","author":"Azevedo","year":"2020","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ejpb.2021.03.013_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13346-017-0357-8","article-title":"Synthesis and characterization of chitosan-grafted-polycaprolactone micelles for modulate intestinal paclitaxel delivery","volume":"8","author":"Almeida","year":"2018","journal-title":"Drug Delivery Translational Res."},{"key":"10.1016\/j.ejpb.2021.03.013_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110920","article-title":"Novel amphiphilic chitosan micelles as carriers for hydrophobic anticancer drugs","volume":"112","author":"Almeida","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2021.03.013_b0075","unstructured":"Loon, J. J. W. A. v.; Krausse, J.; Cunha, H.; Gon\u00c1alves, J.; Almeida, H.; Schiller, P. In The Large Diameter Centrifuge, LDC, for Life and Physical Sciences and Technology, 2008."},{"issue":"3","key":"10.1016\/j.ejpb.2021.03.013_b0080","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1115\/1.1574521","article-title":"Inertial Shear Forces and the Use of Centrifuges in Gravity Research. What is the Proper Control?","volume":"125","author":"van Loon","year":"2003","journal-title":"J. Biomech. Eng."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0085","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1038\/s41598-018-24148-x","article-title":"Study of mucin turnover in the small intestine by in vivo labeling","volume":"8","author":"Schneider","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ejpb.2021.03.013_b0090","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejpb.2021.03.013_b0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2011.11.023","article-title":"Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles","volume":"880","author":"Martins","year":"2012","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2013.10.003","article-title":"Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies","volume":"458","author":"Ara\u00fajo","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2021.03.013_b0105","series-title":"Concepts and Models for Drug Permeability Studies","first-page":"57","article-title":"3.3 - Cell-based in vitro models for intestinal permeability studies","author":"Pereira","year":"2016"},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0110","doi-asserted-by":"crossref","first-page":"C148","DOI":"10.1152\/ajpcell.00524.2003","article-title":"Influence of increased mechanical loading by hypergravity on the microtubule cytoskeleton and prostaglandin E2 release in primary osteoblasts","volume":"289","author":"Searby","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"12","key":"10.1016\/j.ejpb.2021.03.013_b0115","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1089\/scd.2017.0206","article-title":"Continuous Exposure to Simulated Hypergravity-Induced Changes in Proliferation, Morphology, and Gene Expression of Human Tendon Cells","volume":"27","author":"Costa-Almeida","year":"2018","journal-title":"Stem Cells Dev."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0120","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41598-017-18561-x","article-title":"Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6107(02)00037-8","article-title":"Tight junction proteins","volume":"81","author":"Gonzalez-Mariscal","year":"2003","journal-title":"Prog. Biophys. Mol. Biol"},{"key":"10.1016\/j.ejpb.2021.03.013_b0130","doi-asserted-by":"crossref","first-page":"2645465","DOI":"10.1155\/2018\/2645465","article-title":"Tight Junction in the Intestinal Epithelium: Its Association with Diseases and Regulation by Phytochemicals","volume":"2018","author":"Lee","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5217\/ir.2015.13.1.11","article-title":"Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases","volume":"13","author":"Lee","year":"2015","journal-title":"Intest. Res."},{"issue":"6","key":"10.1016\/j.ejpb.2021.03.013_b0140","doi-asserted-by":"crossref","first-page":"G1054","DOI":"10.1152\/ajpgi.00055.2011","article-title":"Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier","volume":"300","author":"Al-Sadi","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.ejpb.2021.03.013_b0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"Gunzel","year":"2013","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.ejpb.2021.03.013_b0150","doi-asserted-by":"crossref","first-page":"F1078","DOI":"10.1152\/ajprenal.00116.2003","article-title":"Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins","volume":"285","author":"Van Itallie","year":"2003","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"Pt 11","key":"10.1016\/j.ejpb.2021.03.013_b0155","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1242\/jcs.060665","article-title":"Claudin-2, a component of the tight junction, forms a paracellular water channel","volume":"123","author":"Rosenthal","year":"2010","journal-title":"J. Cell Sci."},{"issue":"43","key":"10.1016\/j.ejpb.2021.03.013_b0160","doi-asserted-by":"crossref","first-page":"44785","DOI":"10.1074\/jbc.M406563200","article-title":"Establishment and characterization of cultured epithelial cells lacking expression of ZO-1","volume":"279","author":"Umeda","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1741-7015-2-16","article-title":"Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)","volume":"2","author":"Lalloo","year":"2004","journal-title":"BMC Med."},{"issue":"10","key":"10.1016\/j.ejpb.2021.03.013_b0170","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ejpb.2021.03.013_b0175","doi-asserted-by":"crossref","first-page":"C807","DOI":"10.1152\/ajpcell.00234.2008","article-title":"Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif","volume":"295","author":"Ye","year":"2008","journal-title":"American J. Physiol.-Cell Physiol."},{"issue":"4","key":"10.1016\/j.ejpb.2021.03.013_b0180","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1016\/S0021-9258(18)53865-5","article-title":"Increased mdr-1\/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists","volume":"268","author":"Herzog","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1440-1681.2009.05252.x","article-title":"Multidrug resistance-associated proteins and implications in drug development","volume":"37","author":"Liu","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"8","key":"10.1016\/j.ejpb.2021.03.013_b0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2174\/138920007782798171","article-title":"Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs","volume":"8","author":"Yu","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"5","key":"10.1016\/j.ejpb.2021.03.013_b0195","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00424-003-1192-y","article-title":"The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction","volume":"447","author":"Hediger","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejpb.2021.03.013_b0200","doi-asserted-by":"crossref","unstructured":"Ober, R. J.; Martinez, C.; Vaccaro, C.; Zhou, J.; Ward, E. S., Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. Journal of immunology (Baltimore, Md. : 1950) 2004, 172 (4), 2021-9.","DOI":"10.4049\/jimmunol.172.4.2021"},{"issue":"14","key":"10.1016\/j.ejpb.2021.03.013_b0205","doi-asserted-by":"crossref","first-page":"E2862","DOI":"10.1073\/pnas.1618291114","article-title":"Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury","volume":"114","author":"Pyzik","year":"2017","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.ejpb.2021.03.013_b0210","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2021.03.013_b0215","doi-asserted-by":"crossref","unstructured":"Fischer, A. H.; Jacobson, K. A.; Rose, J.; Zeller, R., Hematoxylin and eosin staining of tissue and cell sections. CSH protocols 2008, 2008, pdb.prot4986.","DOI":"10.1101\/pdb.prot4986"},{"key":"10.1016\/j.ejpb.2021.03.013_b0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.carbpol.2017.08.114","article-title":"Self-aggregates of 3, 6-O, O\u2019-dimyristoylchitosan derivative are effective in enhancing the solubility and intestinal permeability of camptothecin","volume":"177","author":"Silva","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejpb.2021.03.013_b0225","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.colsurfb.2017.01.029","article-title":"Synthesis and characterization of 3, 6-O, O\u2019-dimyristoyl chitosan micelles for oral delivery of paclitaxel","volume":"152","author":"Silva","year":"2017","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.ejpb.2021.03.013_b0230","doi-asserted-by":"crossref","unstructured":"Silva, D. S.; M dos Santos, D.; Almeida, A.; Marchiori, L.; Campana-Filho, S. P.; Ribeiro, S. J.; Sarmento, B., N-(2-hydroxy)-propyl-3-trimethylammonium, o-mysristoyl chitosan enhances the solubility and intestinal permeability of anticancer curcumin. Pharmaceutics 2018, 10 (4), 245.","DOI":"10.3390\/pharmaceutics10040245"},{"issue":"3","key":"10.1016\/j.ejpb.2021.03.013_b0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/17425247.2018.1420050","article-title":"Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery","volume":"15","author":"Sgorla","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2021.03.013_b0240","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijbiomac.2019.07.030","article-title":"Zein-casein-lysine multicomposite nanoparticles are effective in modulate the intestinal permeability of ferulic acid","volume":"138","author":"Heep","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2021.03.013_b0245","doi-asserted-by":"crossref","unstructured":"Macedo, M. H.; Martinez, E.; Barrias, C.; Sarmento, B., Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds. Frontiers in Bioengineering and Biotechnology 2020, 8 (1076).","DOI":"10.3389\/fbioe.2020.524018"},{"issue":"6","key":"10.1016\/j.ejpb.2021.03.013_b0250","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/nu10060685","article-title":"Small Intestinal Permeability and Gut-Transit Time Determined with Low and High Molecular Weight Fluorescein Isothiocyanate-Dextrans in C3H Mice","volume":"10","author":"Woting","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ejpb.2021.03.013_b0255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1089\/ten.tec.2012.0463","article-title":"Development of an Improved Three-Dimensional In Vitro Intestinal Mucosa Model for Drug Absorption Evaluation","volume":"19","author":"Li","year":"2013","journal-title":"Tissue Eng. Part C Meth."},{"issue":"3","key":"10.1016\/j.ejpb.2021.03.013_b0260","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13206-017-1307-8","article-title":"Three-dimensional in vitro Gut Model on a Villi-shaped Collagen Scaffold","volume":"11","author":"Yi","year":"2017","journal-title":"Biochip J"},{"issue":"1","key":"10.1016\/j.ejpb.2021.03.013_b0265","doi-asserted-by":"crossref","first-page":"17531","DOI":"10.1038\/s41598-019-53862-3","article-title":"A Simulated Microgravity Environment Causes a Sustained Defect in Epithelial Barrier Function","volume":"9","author":"Alvarez","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ejpb.2021.03.013_b0270","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.asr.2010.05.002","article-title":"Modelling the effects of microgravity on the permeability of air interface respiratory epithelial cell layers","volume":"46","author":"dos Santos","year":"2010","journal-title":"Adv. Space Res."},{"issue":"4","key":"10.1016\/j.ejpb.2021.03.013_b0275","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1208\/s12248-008-9068-x","article-title":"P-gp inhibition potential in cell-based models: which \u201ccalculation\u201d method is the most accurate?","volume":"10","author":"Balimane","year":"2008","journal-title":"The AAPS journal"},{"key":"10.1016\/j.ejpb.2021.03.013_b0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.isci.2018.03.015","article-title":"Bioprinted 3D primary human intestinal tissues model aspects of native physiology and ADME\/Tox functions","volume":"2","author":"Madden","year":"2018","journal-title":"IScience"},{"issue":"5","key":"10.1016\/j.ejpb.2021.03.013_b0285","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1021\/acs.molpharmaceut.8b01143","article-title":"Development of simplified in vitro P-glycoprotein substrate assay and in silico prediction models to evaluate transport potential of P-glycoprotein","volume":"16","author":"Ohashi","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2021.03.013_b0290","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.ejpb.2021.03.013_b0295","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2217\/nnm-2018-0029","article-title":"Intestinal uptake and transport of albumin nanoparticles: potential for oral delivery","volume":"13","author":"Hashem","year":"2018","journal-title":"Nanomedicine (London, England)"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641121000801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:41:56Z","timestamp":1760546516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641121000801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":59,"alternative-id":["S0939641121000801"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.03.013","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of hypergravity in intestinal permeability of nanoformulations and molecules","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2021.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}